Literature DB >> 15673766

Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.

Mathias W R Pletz1, Lesley McGee, Bernard Beall, Cynthia G Whitney, Keith P Klugman.   

Abstract

Mutations in the topoisomerase type II enzymes account for fluoroquinolone resistance in Streptococcus pneumoniae. These mutations can arise spontaneously or be transferred by intraspecies or interspecies recombination, primarily with viridans streptococci. We analyzed the nucleotide sequences of the quinolone resistance-determining regions of 49 invasive levofloxacin-resistant pneumococcal isolates and did not find any evidence for interspecies recombination.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673766      PMCID： PMC547348          DOI： 10.1128/AAC.49.2.779-780.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  D J Bast; J C de Azavedo; T Y Tam; L Kilburn; C Duncan; L A Mandell; R J Davidson; D E Low
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.

Authors:  Bernard Beall; M Catherine McEllistrem; Robert E Gertz; David J Boxrud; John M Besser; Lee H Harrison; James H Jorgensen; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

3.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.

Authors:  C Janoir; I Podglajen; M D Kitzis; C Poyart; L Gutmann
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

5.  Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.

Authors:  M J Ferrándiz; J Oteo; B Aracil; J L Gómez-Garcés; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.

Authors:  R Hakenbeck; N Balmelle; B Weber; C Gardès; W Keck; A de Saizieu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.

Authors:  H Wisplinghoff; R R Reinert; O Cornely; H Seifert
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

9.  Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.

Authors:  Mathias W R Pletz; Lesley McGee; James Jorgensen; Bernard Beall; Richard R Facklam; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Authors:  Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney
Journal:  Clin Infect Dis       Date:  2003-11-03       Impact factor: 9.079
View more
  9 in total

1.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  First characterization of fluoroquinolone resistance in Streptococcus suis.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Ana Catalan; Adela G de la Campa; Estefania Rivero; Gema Lopez; Lucas Dominguez; Miguel Angel Moreno; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread.

Authors:  Michael J Stanhope; Stacey L Walsh; Julie A Becker; Michael J Italia; Karen A Ingraham; Michael N Gwynn; Tom Mathie; James A Poupard; Linda A Miller; James R Brown; Heather Amrine-Madsen
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 4.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

5.  Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.

Authors:  M W R Pletz; L McGee; C A Van Beneden; S Petit; M Bardsley; M Barlow; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.

Authors:  Nicole Wolter; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 7.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

8.  Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.

Authors:  Margaret Ip; Shirley S L Chau; Fang Chi; Julian Tang; Paul K Chan
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

9.  Deciphering the distance to antibiotic resistance for the pneumococcus using genome sequencing data.

Authors:  Fredrick M Mobegi; Amelieke J H Cremers; Marien I de Jonge; Stephen D Bentley; Sacha A F T van Hijum; Aldert Zomer
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.